• Molnupiravir Blocks Bourbon Virus Pathology in Mice Models

  2026-05-21

  This study demonstrates that molnupiravir, a broad-spectrum antiviral, effectively inhibits Bourbon virus replication and prevents lethal disease in a mouse model. The findings advance understanding of nucleoside analogue efficacy against emerging tick-borne RNA viruses and highlight avenues for translational antiviral research.

• CB-5083: Precision Disruption of Protein Homeostasis in Onco

  2026-05-20

  Explore how CB-5083, a potent p97 inhibitor, enables next-level oncology research by precisely disrupting protein homeostasis. This article uniquely integrates structural, mechanistic, and translational insights while guiding practical assay design.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-05-20

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide used for efficient amide bond formation in peptide synthesis and bioconjugation protocols. It is designed for controlled, in vitro applications and is not validated for in vivo or clinical workflows.

• AMPK Suppresses ULK1-Driven Autophagy: New Paradigms in Ener

  2026-05-19

  This study overturns the prevailing view that AMPK activates autophagy during glucose starvation, revealing instead that AMPK inhibits ULK1 and thus restrains autophagy induction. The findings reshape our understanding of cellular energy stress responses, with implications for experimental design in autophagy and vesicle trafficking research.

• Applied Workflows for Plerixafor (AMD3100) in CXCR4 Pathway

  2026-05-19

  Plerixafor (AMD3100) empowers researchers to dissect the CXCL12/CXCR4 axis with precision, enhancing studies in cancer metastasis inhibition, hematopoietic stem cell mobilization, and immunology. This article delivers actionable experimental workflows, troubleshooting insights, and comparative evidence to maximize reproducibility and translational impact using APExBIO's Plerixafor.

• AMPK Revisited: Suppression of Autophagy Under Energy Stress

  2026-05-18

  This study overturns the long-held view that AMPK directly stimulates autophagy during energy stress, revealing instead that AMPK suppresses autophagy initiation via inhibition of ULK1. The findings reshape our understanding of energy-sensing pathways and provide guidance for designing experiments probing the AMPK-ULK1-Vps34 axis.

• SAR405 and Vps34: Redefining Autophagy Control in Cellular S

  2026-05-18

  Explore how SAR405, a potent Vps34 inhibitor, enables new precision in autophagy research. This article uniquely deciphers energy stress signaling and protocol design, advancing beyond prior content with actionable insights for cancer and lysosomal dysfunction models.

• Cyclosporin A in T-Cell Suppression: Protocols and Innovatio

  2026-05-17

  Cyclosporin A, the archetypal immunosuppressive cyclic undecapeptide, underpins precise inhibition of T-cell activation and mitochondrial permeability transition in both in vitro and in vivo models. Grounded by recent mechanistic breakthroughs, this guide translates cutting-edge findings into actionable workflows, troubleshooting strategies, and advanced use-cases for researchers leveraging APExBIO's Cyclosporin.

• 3D Osteocyte Networks Respond to Pulsatile Fluid Flow via Co

  2026-05-16

  This study develops a microfluidic model enabling real-time analysis of 3D osteocyte networks under defined pulsatile unidirectional fluid flow stimuli (PUFFS). It reveals that mechanotransduction through connexin 43-mediated signaling governs network-wide calcium responses, offering a platform for probing dynamic skeletal cell communication.

• Perineuronal Net Degradation Drives Social Memory Loss in AD

  2026-05-15

  This study reveals that the loss of perineuronal nets (PNNs) in the hippocampal CA2 region underlies social cognition deficits in an Alzheimer's disease (AD) mouse model. Chronic matrix metalloproteinase (MMP) inhibition preserves PNN integrity and delays social memory loss, highlighting PNNs as a promising therapeutic target in AD.

• Dehydroabietic Acid: Dual PPAR-α/γ Agonist for Metabolic Res

  2026-05-15

  Dehydroabietic acid enables high-precision modulation of lipid metabolism and insulin sensitivity in metabolic disorder research. This article unpacks robust protocol guidance, troubleshooting strategies, and actionable insights—bridging the latest digestion findings with practical assay design.

• AI-Derived Prognostic Signature Enhances HCC Risk Stratifica

  2026-05-14

  This large-scale, multi-center study introduces a consensus artificial intelligence-driven prognostic signature (CAIPS) for hepatocellular carcinoma (HCC), integrating ten machine learning algorithms across over 1,100 patient samples. CAIPS demonstrates improved prognostic accuracy, identifies therapeutic candidates, and provides mechanistic insights into tumor biology, offering a robust framework for personalized HCC management.

• Lycium barbarum Polysaccharide Counters SO via AMPK/PINK1/Pa

  2026-05-14

  This study demonstrates that Lycium barbarum polysaccharide (LBP) mitigates high-fat-diet-induced skeletal muscle atrophy by activating AMPK/PINK1/Parkin-mediated mitophagy. These findings highlight a novel intervention point for sarcopenic obesity and underscore the importance of mitochondrial quality control in muscle metabolic health.

• Plerixafor (AMD3100): Optimizing CXCR4 Antagonism in Researc

  2026-05-13

  Plerixafor (AMD3100) empowers rigorous CXCR4 axis interrogation, unlocking advanced cancer metastasis inhibition and hematopoietic stem cell mobilization workflows. This guide provides actionable protocols, troubleshooting insights, and cross-study comparisons to drive reproducibility and innovation in oncology and immune signaling research.

• Optimizing hiPSC-Derived Platelet Production: Protocol Advan

  2026-05-13

  This study presents a systematically optimized protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs), emphasizing small molecule substitution for cytokines and enhanced megakaryocyte maturation. The approach significantly shortens differentiation time and reduces cost, offering a scalable solution for ex vivo platelet production in research and therapeutic contexts.

7926 records 14/529 page Previous Next First page 上5页 1112131415 下5页 Last page